Beam Therapeutics Inc.
BEAM
$31.58
-$0.17-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -65.04M | -79.05M | -413.70M | -397.64M | -386.40M |
| Total Depreciation and Amortization | 22.37M | 22.29M | 22.07M | 21.98M | 22.02M |
| Total Amortization of Deferred Charges | 35.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -165.94M | -157.33M | 103.36M | 99.22M | 110.73M |
| Change in Net Operating Assets | -161.16M | -131.02M | -49.91M | -68.38M | -97.73M |
| Cash from Operations | -369.73M | -345.10M | -338.18M | -344.82M | -351.38M |
| Capital Expenditure | -14.11M | -14.95M | -14.18M | -10.75M | -9.57M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -78.00K | -78.00K | -78.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.11M | -106.41M | -89.31M | -133.77M | 122.96M |
| Cash from Investing | 28.92M | -121.44M | -103.57M | -144.52M | 113.38M |
| Total Debt Issued | 93.89M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -201.00K | -308.00K |
| Issuance of Common Stock | 8.21M | 478.05M | 479.61M | 479.40M | 478.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -813.00K | -- | -- | -- | -- |
| Cash from Financing | 101.28M | 478.05M | 479.61M | 479.19M | 478.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -239.53M | 11.51M | 37.86M | -10.15M | 240.22M |